NCT02822469

Brief Summary

Background: Different therapeutic approaches have been proposed for the treatment of TMD. Myofascial and joint techniques, exercises, intraoral devices, thermal, electro and phototherapy applications, are among the most common. The combination of local treatments and adjacent structures such as the cervical region have also been studied in this area. It is believed that the anatomic proximity, neuronal interconnections and convergent afferents from the trigeminal and cervical areas can lead the understanding of the relationship of these structures. In order to assess the effects of these different forms of treatment studies have used different resources such as diagnostic imaging and biological signals, in order to complement the clinical diagnosis. Infrared thermography has been one of the resource assessment in the literature and it is interesting and stands out from other methods because it is functional, non-invasive and inexpensive. Purpose: To evaluate the thermograms concerning the masseter and anterior temporal muscles, severity, pain, range of mandibular motion and neck disability in TMD patients, before and after physical therapy applied to the cervical and thoracic regions. Methods: This is a randomized, placebo-controlled study, designed to evaluate the effects of indirect treatment on the thermography of the masticatory muscles, severity, pain, range of motion and neck disability in individuals with TMD. These will be randomized and allocated into two groups: GA (intervention) and GB (placebo) and assessed as: Diagnostic Criteria for Temporomandibular Research Disorders (RDC/TMD), Fonseca´s Anamnesic Index (FAI), Thermography, EVA, IDD-CF, Pachymetry and Neck Disability Index (NDI). Statistical analysis: The temperature of the orofacial region, acquired through thermography is considered the primary endpoint and as a secondary endpoint will be the evaluation of the severity according to FAI, pain by VAS and IDD-CF, the range of mandibular motion by pachymetry and neck disability by NDI. Statistical analysis: The normality of the data will be verified using the Kolmogorov-Smirnov test, which will be expressed as mean and standard deviation and/or median and interquartile range. Repeated measures analysis of variance of two factors, post hoc Bonferroni will be used for inter and intra-group comparisons. The significance level of p≤0.05 is set.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2016

Completed
8 days until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 4, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

February 21, 2022

Status Verified

February 1, 2022

Enrollment Period

1.3 years

First QC Date

June 23, 2016

Last Update Submit

February 18, 2022

Conditions

Keywords

TMD Infrared Thermography Physical Therapy Modalities

Outcome Measures

Primary Outcomes (1)

  • Changes in Skin Temperature

    Measured by the Infrared thermographic digital camera

    Baseline and 4 weeks

Secondary Outcomes (5)

  • Changes in TMD severity

    Baseline and 4 weeks

  • Changes in Neck disability

    Baseline and 4 weeks

  • Changes in Pain incapacity

    Baseline and 4 weeks

  • Changes in Movement Range of Motion (Opening)

    Baseline and 4 weeks

  • Changes in Referred Pain

    Baseline and 4 weeks

Study Arms (2)

Manual Therapy Treatment Group

EXPERIMENTAL

Severe and Moderate TMD patients who filled the inclusion criteria who will receive the Manual Therapy Treatment

Other: Manual Therapy Treatment

Placebo Ultrasound Treatment Group

PLACEBO COMPARATOR

Severe and Moderate TMD patients who filled the inclusion criteria who will receive the Placebo Treatment.

Device: Placebo Ultrasound

Interventions

Treatment starts with 10 deep breathing movements for global relaxation. The anterior and posterior neck muscles, shoulder girdle and subdiaphragmatic will be addressed with myofascial techniques repeated 10 times in each stroke. The cervical spine will be pulled in the longitudinal direction. The draw will be held 1 time, lasting 1 minute. The thoracic region will receive mobilization technique in the anteroposterior direction,10 repeated movements involving all thoracic segment. The treatment will be applied previously trained therapists, 4 weeks, 2 times a week, totaling eight sessions. The treatment time per session is about 25 minutes.

Manual Therapy Treatment Group

A detuned pulsed ultrasound will be applied to regions of the muscles around the shoulder girdle and anterior posterior cervical, for 25 minutes (2.5 minutes in each zone ). The device will be used with the internal cables disconnected for the placebo effect . However, you can handle it and adjust the doses and alarms as it is connected in order to simulate clinical practice and increase the credibility of the use of this device in the voluntary . The placebo treatment will be applied by previously trained therapists. Treatment will have 4 weeks, 2 times a week, totaling eight sessions.

Placebo Ultrasound Treatment Group

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18 and 45 years;
  • presence of pain in the facial region in the last 6 months;
  • diagnosis of myofascial pain (I) and/or disc displacement (IIa and IIb) determined by the DRC/TMD; Moderate DTM Record carrier or determined by Fonseca Anamnesic Index.

You may not qualify if:

  • A history of trauma/cervical surgery and/or craniofacial;
  • Neurological disorders;
  • cervical disc disease;
  • degenerative diseases of the spine;
  • systemic diseases;
  • diagnosis of fibromyalgia;
  • prior treatments for TMD for the last 3 months;
  • orthodontic treatment/orthopedic in progress;
  • continuous use of analgesics, anti-inflammatories, anxiolytics and/or antidepressants;
  • BMI\> 25 kg / m2;
  • pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nove de Julho

São Paulo, São Paulo, 01415000, Brazil

Location

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Study Officials

  • Daniela Ap Biasotto-Gonzalez, PHD

    Study Principal Investigator - Universidade Nove de Julho

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
DR

Study Record Dates

First Submitted

June 23, 2016

First Posted

July 4, 2016

Study Start

July 1, 2016

Primary Completion

October 1, 2017

Study Completion

December 1, 2017

Last Updated

February 21, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations